Most known breast cancer risk or protective factors are related to luminal or hormone receptor (ER or PR) positive tumors, whereas less is known about the etiology of triple-negative (TN) tumors, an aggressive subtype[4, 5]. This evidence concerns the gene ESR1 and breast cancer.